Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,470.00
-260.00 (-2.98%)
At close: Apr 9, 2026

Hyundai Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Dec - Nov.
Fiscal Year
CurrentFY 2013FY 2012FY 2011FY 2010FY 2009
Period Ending
Apr '26 Nov '13 Nov '12 Nov '11 Nov '10 Nov '09
241,62642,44336,22927,90538,34055,972
Market Cap Growth
169.44%17.15%29.83%-27.22%-31.50%-0.39%
Enterprise Value
-48,44543,62036,76149,20869,151
Last Close Price
8730.001581.881318.83992.311318.311788.54
PE Ratio
144.6930.00-53.6512.9233.50
PS Ratio
2.230.390.350.240.340.46
PB Ratio
2.390.420.360.270.410.60
P/TBV Ratio
2.440.430.370.280.420.61
P/FCF Ratio
42.327.43-10.79--
P/OCF Ratio
30.395.34-4.4514.32-
EV/Sales Ratio
-0.450.430.320.440.56
EV/EBITDA Ratio
-11.27-6.2035.0018.32
EV/EBIT Ratio
-22.15-10.62-59.08
EV/FCF Ratio
-8.49-14.22--
Debt / Equity Ratio
0.210.210.290.270.240.25
Debt / EBITDA Ratio
4.834.83-4.6915.656.23
Debt / FCF Ratio
3.633.63-10.76--
Net Debt / Equity Ratio
0.060.060.130.130.120.17
Net Debt / EBITDA Ratio
1.421.42-6.462.347.604.20
Net Debt / FCF Ratio
1.071.07-3.055.36-8.43-1.72
Asset Turnover
0.740.740.670.790.840.93
Inventory Turnover
3.003.003.074.414.424.89
Quick Ratio
1.621.621.411.551.801.64
Current Ratio
2.202.201.971.942.212.07
Return on Equity (ROE)
1.45%1.45%-4.75%0.55%3.21%1.80%
Return on Assets (ROA)
0.93%0.93%-1.76%1.50%-0.42%0.55%
Return on Invested Capital (ROIC)
2.04%1.99%-3.75%0.95%-0.65%0.98%
Return on Capital Employed (ROCE)
2.00%2.00%-4.10%3.10%-0.90%1.20%
Earnings Yield
0.59%3.33%-13.39%1.86%7.74%2.99%
FCF Yield
2.36%13.45%-11.47%9.27%-3.31%-16.46%
Dividend Yield
0.36%---3.41%2.80%
Payout Ratio
62.32%62.32%-202.97%41.25%95.71%
Buyback Yield / Dilution
-0.08%-0.08%0.90%0.97%2.94%7.44%
Total Shareholder Return
0.27%-0.08%0.90%0.97%6.35%10.23%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.